Seasonal Influenza Vaccination Programs in the Americas: A Platform for Sustainable Life-Course Immunization and Its Role for Pandemic Preparedness and Response.

Publication date: Dec 16, 2024

Background: Vaccination is one of the most effective measures to prevent influenza illness and its complications. Since the 1980s, countries and territories in the Americas have progressively implemented influenza vaccination operations in high-risk priority groups-such as older adults, pregnant persons, persons with comorbidities and health workers. Methods: In this review, we present the history and progress of the seasonal influenza program in the Americas, how the program contributed to the efficient and timely roll-out of the COVID-19 vaccines during the pandemic, and how the program can be used to promote immunization operations across the life span for existing and future vaccines. Results: The influenza A(H1N1)pdm09 pandemic in 2009 and the COVID-19 pandemic in 2020-2023 underscored the importance of having a robust seasonal influenza vaccination program for pandemic preparedness and response. Overall, countries with existing seasonal influenza vaccination programs were better prepared and rolled out the delivery of COVID-19 vaccines more quickly and effectively compared to other countries where the influenza vaccination platform was weak or non-existent. Conclusions: Traditionally, national immunization programs of developing countries have been predominately focused on newborns, children younger than five years and school-aged children while often limiting their investment in effective adult vaccination programs; these programs are typically isolated to high-income countries. Countries in Latin America have been the exception, with strong influenza vaccination programs for adults regardless of national income level. The presence of functional and effective adult influenza vaccination programs can also facilitate the acceptance and uptake of other adult vaccines targeting priority groups at higher risk for severe illness or complications.

Open Access PDF

Concepts Keywords
Ah1n1pdm09 COVID-19
Americas immunization
Severe influenza
Vaccination life-course immunization
maternal vaccination
outbreaks
respiratory syncytial virus
vaccines

Semantics

Type Source Name
disease MESH Influenza
disease IDO role
disease MESH complications
disease IDO history
pathway KEGG Influenza A
disease MESH COVID-19 pandemic
drug DRUGBANK Tropicamide
disease MESH Emergencies
disease MESH Respiratory Diseases
disease IDO country
drug DRUGBANK Coenzyme M
disease MESH morbidity
disease MESH infections
disease IDO infection
disease MESH chronic diseases
disease IDO quality
disease IDO facility
disease MESH respiratory infections
drug DRUGBANK Spinosad
drug DRUGBANK Etoperidone
drug DRUGBANK Nonoxynol-9
disease MESH vaccine preventable diseases
disease MESH death
disease MESH preterm birth
disease MESH tetanus
disease MESH diphtheria
disease MESH pertussis
pathway KEGG Pertussis
drug DRUGBANK Filgrastim
disease IDO process
drug DRUGBANK Naproxen
disease MESH Parainfluenza

Original Article

(Visited 1 times, 1 visits today)